About BBI Group
BBI Group is a company based in Cardiff (United Kingdom) founded in 1986 was acquired by Novo Holdings in June 2021. BBI Group has completed 1 acquisition, including Diarect. BBI Group offers products and services including Reagents, Antibody Development, and Lateral Flow Services. BBI Group operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Cardiff, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bbi Solutions Limited
- Date of Incorporation 15 Jan, 2008
- Jurisdiction NOTTINGHAMSHIRE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Exponent
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BBI Group
BBI Group offers a comprehensive portfolio of products and services, including Reagents, Antibody Development, and Lateral Flow Services.
Suite of antigens, antibodies, and enzymes for IVD applications
Custom development for diagnostic immunoassays
Development and production of rapid diagnostic tests
Funding Insights of BBI Group
Detailed funding history for BBI Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BBI Group
BBI Group has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Exponent and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Exponent is engaged in private equity investments across Europe.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for BBI Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BBI Group
BBI Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Diarect.
Investment portfolio details for BBI Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Recombinant and native antigens
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for BBI Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BBI Group
Detailed financials for BBI Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bbi Group Comparisons
Peer comparison for BBI Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BBI Group
BBI Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of BBI Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bbi Group
Complete news archive for BBI Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BBI Group
BBI Group was founded in 1986.
BBI Group is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
BBI Group was founded in 1986 and is headquartered in Cardiff, United Kingdom. A portfolio of products and services is developed for the diagnostic, healthcare, research, defense, and food industries. Raw materials for diagnostic tests and consumer health products are offered, along with instruments such as the IsoFlow Bench-top reagent dispenser and reel-to-reel system for lateral flow test manufacturing. Contract services are provided, including antibody production and warehousing solutions.
BBI Group's top competitors include Sino Biological, GenScript and Y-Biologics.
BBI Group offers Reagents, Antibody Development, and Lateral Flow Services.
BBI Group has made 1 acquisition, including Diarect.
BBI Group has 2 investors. Key investors include Exponent, and Novo Holdings.